Yuan-Soon Ho

Professor, School of Medical Laboratory Science and Biotechnology
Joint-Appointment Professor, International Master/Ph.D. Program in Medicine
Joint-Appointment Professor, Master Program in Applied Molecular Epidemiology
Joint-Appointment Professor, Ph.D. Program in Medical Biotechnology
Associate Director, TMU Research Center of Cancer Translational Medicine

https://orcid.org/0000-0002-3649-6680

Emailhoyuansn@tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

1994 Ph.D., Department of Biochemical Science Technology, National Taiwan University
1990 M.S., Department of Biochemical Science Technology, National Taiwan University
1989 M.D., Medical Laboratory Science and Biotechnology, Taipei Medical University

Experience

2018.12- Professor, Department of Medical Laboratory Science and Biotechnology, Taipei Medical University
2018.04- Professor, Master Program in Applied Molecular Epidemiology, Taipei Medical University
2017- Vice Director, Research Center of Cancer Translational Medicine, Taipei Medical University
2016.11- Professor, International Master Program in Medicine, Taipei Medical University
2016.11- Professor, International Ph.D Program in Medicine, Taipei Medical University
2015.02-2018.11 Professor, Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan
2015.02-2018.08 Director, Graduate Institute of Medical Science, Taipei Medical University
2015.02-2018.11 Professor, Graduate Institute of Medical Science, Taipei Medical University
2011.02-2015.01 Professor, Department of Medical Laboratory Science and Biotechnology, Taipei Medical University

Awards

2019 International Top Journal Publication Award, Taipei Medical University

Fingerprint

Dive into the research topics where Yuan-Soon Ho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

8 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Active
35 Finished

組織胺甲基化轉換酵素(HNMT)輔助臨床醫師鑑別乳癌病患作為Herceptin療效評估之新穎分子標記(2/3)
Ho, Y.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
乳癌細胞α9尼古丁受體作為新穎靶向RNA奈米藥物與T細胞療法之臨床轉譯研究-乳癌細胞α9尼古丁受體/HER2複合體作為RNA奈米藥物治療HerceptinR抗藥性之機制探討(1/3)
Ho, Y.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
Investigating the Oncogenic Roles of A9-Nicotinic Acetylcholine Receptor Variants on Breast Cancer( III )
Ho, Y.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Studies on the Mechanisms of Histamine N-Methyl-Transferase (Hnmt) as a Novel Molecular Marker to Help Clinician for Identifying of Herceptin Responder in Breast Cancer Patients(1/3)
Ho, Y.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Investigating the Oncogenic Roles of A9-Nicotinic Acetylcholine Receptor Variants on Breast Cancer(II)(2/3)
Ho, Y.
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology

5892 Citations
41 h-Index
157 Article
6 Review article
3 Conference contribution
1 Comment/debate
More
- 1 Patent

Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects
Lee, W. J., Cheng, T. C., Yen, Y., Fang, C. L., Liao, Y. C., Kuo, C. C., Tu, S. H., Lin, L. C., Chang, H. W., Chen, L. C. & Ho, Y. S., 2021, In: Journal of Food and Drug Analysis. 29, 1, p. 113-127 15 p., 9.
Research output: Contribution to journal › Article › peer-review

Open Access
Multi-gene signature of microcalcification and risk prediction among Taiwanese breast cancer
Tsai, H. T., Huang, C. S., Tu, C. C., Liu, C. Y., Huang, C. J., Ho, Y. S., Tu, S. H., Tseng, L. M. & Huang, C. C., Dec 1 2020, In: Scientific Reports. 10, 1, 18276.
Research output: Contribution to journal › Article › peer-review

Open Access
Two new, near-infrared, fluorescent probes as potential tools for imaging bone repair
Lin, C. C., Chang, W. H. S., Cheng, T. M., Chiu, L. H., Wang, Y. H., Lin, C. A. J., Ho, Y. S., Zuo, C. S., Wang, Y. M. & Lai, W. F. T., Dec 1 2020, In: Scientific Reports. 10, 1, 2580.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
A new histone deacetylase inhibitor enhances radiation sensitivity through the induction of misfolded protein aggregation and autophagy in triple-negative breast cancer
Chiu, H. W., Yeh, Y. L., Ho, S. Y., Wu, Y. H., Wang, B. J., Huang, W. J., Ho, Y. S., Wang, Y. J., Chen, L. C. & Tu, S. H., Nov 1 2019, In: Cancers. 11, 11, 1703.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint
Lee, W-H., Chen, L-C., Lee, C-J., Huang, C-C., Ho, Y-S., Yang, P-S., Ho, C-T., Chang, H-L., Lin, I-H., Chang, H-W., Liu, Y-R., Wu, C-H. & Tu, S-H., Feb 1 2019, In: International Journal of Cancer. 144, 3, p. 615-630 16 p.
Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus)

Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. (Contributor), Chen, M. (Contributor), Chen, L. (Contributor), Ho, Y. (Contributor), Ho, H. (Contributor), Lin, S. (Contributor), Chuang, K. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, May 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
Dataset
Additional file 1: of Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells
Wu, K. (Contributor), Lee, W. (Contributor), Cheng, T. (Contributor), Chang, H. (Contributor), Chen, L. (Contributor), Chen, L. (Contributor), Lien, H. (Contributor), Lin, T. (Contributor) & Ho, Y. (Contributor), Unknown Publisher, Jul 27 2019
DOI: 10.6084/m9.figshare.9121481.v1, https://doi.org/10.6084%2Fm9.figshare.9121481.v1
Dataset
Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells
Wu, K. (Contributor), Lee, W. (Contributor), Cheng, T. (Contributor), Chang, H. (Contributor), Chen, L. (Contributor), Chen, L. (Contributor), Lien, H. (Contributor), Lin, T. (Contributor) & Ho, Y. (Contributor), Unknown Publisher, Jul 27 2019
DOI: 10.6084/m9.figshare.c.4591847.v1, https://doi.org/10.6084%2Fm9.figshare.c.4591847.v1
Dataset